The results
Near-parity at seed. Premiums appear later.
In the four-market dataset, T1 companies show larger later-stage rounds, higher observed graduation, and higher exit incidence than the unregulated cohort. The pattern is strongest from Series C onward.
- 2.22x Observed T1 exit incidence vs unregulated cohort
- 1.53x Series C round-size uplift
- 2.12x Cumulative funding uplift by Series D+
- 9 Named acquirer deals, 2020-2026
Named acquirer deals
Strategic acquirers are already buying.
9 named developed-APAC regulated-company acquisitions, source-verified. Highlighted marks show T1 acquisitions. Disclosed values range $193M to $1.64B.
Source: hmm Ventures exit dataset.
Coverage today: AUS 7. NZL 2. JPN 0. SIN 0. Current coverage is uneven. More data is expected as 2026-2028 compliant cohorts mature.
Round-size uplift
T1 companies show larger observed rounds at every stage.
Round-size uplift relative to the unregulated cohort. Seed near parity. The gap opens by Series C.
Source: hmm Ventures four-market dataset.
Exit incidence
T1 companies show 2.22x the observed exit incidence of the unregulated cohort.
Exit incidence: regulated cohort 13.41% vs unregulated 6.03%.
Source: hmm Ventures four-market dataset.
If you allocate capital
Learn more.
A short note on the office, the mandate, and what you have read.
Request a meeting →If you build what people need
Tell us what you are building.
Heal, power, move, supply, eat. Read the doctrine before sending a deck.
Tell us more →